The evolution of cannabinoid receptors in cancer
WIREs Mechanisms of Disease · 2023
DOI: 10.1002/wsbm.1602 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift WIREs Mechanisms of Disease, 2023. Verfasst von Nakea M Pennant und 1 weiteren Autor:innen. Beteiligte Einrichtung: Biological Sciences, Clark Atlanta University, Atlanta, Georgia, USA. Hauptthemen laut MEDLINE: Cannabinoids, Cannabis, Neoplasms, Hallucinogens. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 105 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIGMS NIH HHS, NIMHD NIH HHS, National Institute of General Medical Sciences.
Abstract (Originalsprache)
Cannabis sativa (cannabis) has been used as a therapeutic treatment for centuries treating various diseases and disorders. However, racial propaganda led to the criminalization of cannabis in the 1930s preventing opportunities to explore marijuana in therapeutic development. The increase in recreational use of cannabis further grew concern about abuse, and lead to further restrictions and distribution of cannabis in the 1970s when it was declared to be a Schedule I drug in the USA. In the late 1990s in some states, legislation assisted in legalizing the use of cannabis for medical purposes under physician supervision. As it has been proven that cannabinoids and their receptors play an essential role in the regulation of the physiological and biological processes in our bodies. The endocannabinoid system (ECS) is the complex that regulates the cell‐signaling system consisting of endogenous cannabinoids (endocannabinoids), cannabinoid receptors, and the enzymes responsible for the synthesis and degradation of the endocannabinoids. The ECS along with phytocannabinoids and synthetic cannabinoids serves to be a beneficial therapeutic target in treating diseases as they play roles in cell homeostasis, cell motility, inflammation, pain‐sensation, mood, and memory. Cannabinoids have been shown to inhibit proliferation, metastasis, and angiogenesis and even restore homeostasis in a variety of models of cancer in vitro and in vivo. Cannabis and its receptors have evolved into a therapeutic treatment for cancers. This article is categorized under: Cancer > Molecular and Cellular Physiology
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Biological Sciences, Clark Atlanta University, Atlanta, Georgia, USA.
ORCID-Profile: Nakea M Pennant, Cimona V Hinton
Förderung
- NIGMS NIH HHS
- NIMHD NIH HHS
- National Institute of General Medical Sciences
- National Institute on Minority Health and Health Disparities
- Augusta University
Zitieren
APA
Pennant, N. M., & Hinton, C. V. (2023). The evolution of cannabinoid receptors in cancer. WIREs Mechanisms of Disease. https://doi.org/10.1002/wsbm.1602
Vancouver
Pennant NM, Hinton CV. The evolution of cannabinoid receptors in cancer. WIREs Mechanisms of Disease. 2023. doi:10.1002/wsbm.1602
BibTeX
@article{Pennant2023,
author = {Pennant, Nakea M and Hinton, Cimona V},
title = {The evolution of cannabinoid receptors in cancer},
journal = {WIREs Mechanisms of Disease},
year = {2023},
doi = {10.1002/wsbm.1602}
}
EUVIMED